PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Biotin anti-α-Synuclein Phospho (Ser129), 100 μg
Biotin anti-β-Amyloid, 1-16 , 1 ml
Biotin anti-β-Amyloid, 1-16 , 200 μl
Biotin anti-β-Amyloid, 1-16 , 500 μl
Biotin anti-β-Amyloid, 1-38, 50 μl
Biotin anti-β-Amyloid, 1-40, 200 μl
Biotin anti-β-Amyloid, 1-42 , 200 μl
Biotin anti-β-Amyloid, 1-43 , 200 μl
Biotin anti-β-Amyloid, 17-24 , 1 ml
Biotin anti-β-Amyloid, 17-24 , 200 μl
Biotin anti-β-Amyloid, 17-24 , 500 μl
Biotin anti-β-Amyloid, x-42, 50 μl
Brilliant Violet 605™ anti-mouse CD183 (CXCR3) Antibody, 50 µg
Brilliant Violet 605™ Goat anti-rat IgG (minimal x-reactivity), 50 μg
Brilliant Violet™ 421 anti-CD105 (Endoglin), 100 tests
Brilliant Violet™ 421 anti-CD105 (Endoglin), 25 tests